Yves LeterrierYves Leterrier joined EPFL in 1993 and is a faculty member of the Materials Institute. He is a senior scientist and lecturer in the Laboratory for Processing of Advanced Composites (LPAC, previously Laboratory of Composite and Polymer Technology, LTC). Activities
2000-2005: Foundation and Chair of the Korea-Switzerland joint symposia on materials and micro-technologies2004-2008: Board member of FLEXIDIS (the European flexible display consortium) 2004-2009: Group leader on lightweight materials for Solar ImpulseSince 2008: Board member of the French Adhesion SocietySince 2000: President of the EPFL Materials Science Library commissionSince 2012: Editorial board member, Applied Surface ScienceSince 2014: Associate Editor, Frontiers in MaterialsSince 2021: Coordinator of the EPFL Minor on 'Engineering for Sustainability'
Background
1987: MS in materials science and solid state physics (INPL, France) 1991: PhD in materials science (Ecole des Mines, INPL, France) 1992: Research Associate, National Institute of Standards and Technology (NIST, USA)
Matthias LütolfMatthias Lutolf is Full Professor at EPFL’s Institute of Bioengineering, with a cross appointment in the Institute of Chemical Sciences and Engineering. Lutolf was trained as a Materials Engineer at ETH Zurich where he also carried out his PhD studies (with Jeffrey Hubbell) that were awarded with an ETH medal. He continued his research training as a Post-Doctoral Fellow in Stem Cell Biology (with Helen Blau) at Stanford University. He has served as the Director of the Institute of Bioengineering from 2014 to 2018. Lutolf is an internationally recognized leader in the fields of stem cell bioengineering and tissue engineering. His research program uniquely combines stem cell biology with engineering principles and quantitative thinking. His team, composed of engineers, chemists, physicists, cell and developmental biologists, strives to develop technologies that have true biological and medicinal function and applicability. Lutolf’s work has led to more than 110 peer-reviewed scientific publications, many of which published in highly reputed journals, more than 25 patents, and the commercialization of several products. Current research in the Lutolf lab is focused on the bioengineering of miniature tissues, termed organoids, that are generated from self-organizing stem cells.
